Amoy Diagnostics Co., Ltd. (SHE:300685)

Amoy Diagnostics Revenue

Amoy Diagnostics had revenue of 310.43M CNY in the quarter ending September 30, 2026, with 8.43% growth. This brings the company's total for the last twelve months to 1.20B, up 6.68% year-over-year. In the year 2025, Amoy Diagnostics had annual revenue of 1.20B with 8.01% growth. That makes Amoy Diagnostics the 18,213th largest company in the world by revenue and 3,328th in China.

• Revenue (ttm): 1.20B
• Revenue Growth: +6.68%
• P/S Ratio: 6.05
• Revenue / Employee: 1.02M
• Employees: 1,175
• Market Cap: 7.34B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Testing Reagent Business 951.89M 79.5%
• Drug Clinical Research Services 158.14M 13.2%
• Testing Service Business 77.31M 6.5%
• Unallocated Other Operations 10.39M 0.9%

By Geography

Chart

• China 925.86M 77.3%
• Overseas 271.87M 22.7%

Fiscal year ended Dec 31, 2025 See the full Amoy Diagnostics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.20B	88.78M	8.01%
Dec 31, 2024	1.11B	65.44M	6.27%
Dec 31, 2023	1.04B	201.33M	23.91%
Jan 1, 2023	842.18M	-74.85M	-8.16%
Jan 1, 2022	917.03M	188.64M	25.90%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error